• Featured Product
  • KD/KO Validated

FGFR4 Polyklonaler Antikörper

FGFR4 Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 11098-1-PBS

Synonyme

CD334, EC:2.7.10.1, FGFR 4, FGFR-4, JTK2



Geprüfte Anwendungen

Produktinformation

11098-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA FGFR4 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen FGFR4 fusion protein Ag1573
Vollständiger Name fibroblast growth factor receptor 4
Berechnetes Molekulargewicht 88 kDa
Beobachtetes Molekulargewicht 95, 100-110 kDa
GenBank-ZugangsnummerBC011847
Gene symbol FGFR4
Gene ID (NCBI) 2264
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Fibroblast growth factor receptor 4 (FGFR4) is a member of a highly conserved tyrosine kinase family, along with FGFR1-3. This family consists of an intracellular tyrosine kinase domain, a single transmembrane domain, and extracellular ligand-binding domains (PMID: 32492514). FGFR4 is the predominant FGFR isoform present in human hepatocytes. FGFR4 has been proposed to play a role in the observed induction of hepatocyte proliferation and carcinogenesis by FGF19; however, contradicting evidence proposing a protective role for FGFR4 in suppressing hepatoma progression has also been proposed(PMID: 20018895). While the role of FGFR4 in cancer remains to be fully elucidated, several findings suggest that this receptor may be an important player in Hepatocellular carcinoma (HCC) development and/or progression(PMID: 10336501).